News
10-19-2010, 02:11 AM
The recently signed cooperation agreement between the MPI of Biochemistry and GSK pursues the objective of developing innovative new drugs. The joint research and development work is based on the research findings of Axel Ullrich, Director at the MPI of Biochemistry.
More... (http://www.news-medical.net/news/20101019/MPI-of-Biochemistry-and-GSK-collaborate-in-development-of-new-drugs-for-type-2-diabetes.aspx)
More... (http://www.news-medical.net/news/20101019/MPI-of-Biochemistry-and-GSK-collaborate-in-development-of-new-drugs-for-type-2-diabetes.aspx)